Monitor for a subsequent 8-K announcing the appointment of an auditor for FY2026. The lack of an appointed auditor four days before the annual meeting is a minor governance concern but not yet a material red flag. No trading action warranted based on this filing alone.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Jun 23 $0.4615entry
- T+1 · 5mo ago −9.75%α −9.70% · $0.4165
- T+5 · 5mo ago −22.21%α −23.22% · $0.3590
- T+20 · 4mo ago −56.66%α −57.82% · $0.2000
- T+60 · due 2mo ago Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
BiomX Inc. filed a DEFA14A supplement correcting an error in its proxy statement: the Audit Committee did not appoint Kesselman & Kesselman (PwC Israel) as auditor for FY2026, contrary to the original statement. The company has not yet selected an auditor for FY2026, and the annual meeting proposals remain unchanged.
Key Financial Metrics
Key Facts
- Correction: original proxy statement erroneously stated Kesselman & Kesselman was appointed as auditor for FY2026; no appointment has been made.
- Audit Committee is in the process of selecting an independent registered public accounting firm for FY2026.
- Annual meeting scheduled for June 26, 2026; proposals unchanged (director election, equity plan amendment, adjournment).
- Prior auditor Kesselman & Kesselman served for FY2024 and FY2025 and audited the FY2025 10-K.
Financial Impact
No direct financial impact; potential indirect risk if auditor appointment is delayed, but no material exposure quantified.
Risk Factors
- Delay in auditor appointment could lead to late filing of the FY2026 10-K if not resolved promptly.
- Correction highlights potential internal control or disclosure weaknesses at a micro-cap company.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001213900-26-070669 |
| Document: 0001213900-26-070669-index-headers.html | 0001213900-26-070669 |
| Document: 0001213900-26-070669-index.html | 0001213900-26-070669 |
| Document: 0001213900-26-070669.txt | 0001213900-26-070669 |
Track record
22 reports on PHGE
8 of 12 bullish or bearish reports moved the stock their way by T+1. Best: +62.36% at T+20 after the Jun 16, 2026 report. 8 of 12 went positive at some point.
Filters
- Oct 7, 20265w ago 8-K Neutral 4/10 Entry $0.3092 to $0.2915 ▼ −5.72% −5.30% vs SPY
- Oct 7, 20265w ago DEF 14A Bearish 6/10 Entry $0.3092 to $0.2915 ▲ +5.72% +5.30% vs SPY
- Sep 1, 202610w ago 8-K Neutral 3/10 Entry $0.1425 to $0.1421 ▼ −0.28% −1.33% vs SPY
- Aug 28, 202611w ago 8-K Neutral 4/10 Entry $0.1371 to $0.1430 ▲ +4.30% +4.99% vs SPY
- Aug 5, 202614w ago Press Release Bearish 5/10 Entry $0.1800 to $0.1598 ▲ +11.22% +11.06% vs SPY
- Jul 28, 202615w ago 8-K Bearish 8/10 Entry $0.1834 to $0.1830 ▲ +0.22% −1.32% vs SPY
- Jul 28, 202615w ago Press Release Bearish 7/10 Entry $0.1834 to $0.1830 ▲ +0.22% −1.32% vs SPY
- Jul 27, 202616w ago 424B5 Bearish 7/10 Entry $0.1834 to $0.1830 ▲ +0.22% −1.32% vs SPY
- Jul 8, 202618w ago Press Release Neutral 4/10 Entry $0.2758 to $0.2800 ▲ +1.52% +0.68% vs SPY
- Jul 2, 202619w ago 8-K Bearish 6/10 Entry $0.3190 to $0.3020 ▲ +5.33% +6.20% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers